Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells
Houbo Jiang, Yong Ren, Eunice Y. Yuen, et al.
Nature Communications (2012) Vol. 3, Iss. 1
Open Access | Times Cited: 241

Showing 1-25 of 241 citing articles:

Induced pluripotent stem cell technology: a decade of progress
Yanhong Shi, Haruhisa Inoue, Joseph C. Wu, et al.
Nature Reviews Drug Discovery (2016) Vol. 16, Iss. 2, pp. 115-130
Open Access | Times Cited: 1306
Mitochondrial Regulation in Pluripotent Stem Cells
Xiuling Xu, Shunlei Duan, Fei Yi, et al.
Cell Metabolism (2013) Vol. 18, Iss. 3, pp. 325-332
Closed Access | Times Cited: 360
Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue
Yoichi Imaizumi, Yohei Okada, Wado Akamatsu, et al.
Molecular Brain (2012) Vol. 5, Iss. 1
Open Access | Times Cited: 351
Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development
Peter Karagiannis, Kazutoshi Takahashi, Megumu K. Saito, et al.
Physiological Reviews (2018) Vol. 99, Iss. 1, pp. 79-114
Open Access | Times Cited: 303
Modeling ALS with iPSCs Reveals that Mutant SOD1 Misregulates Neurofilament Balance in Motor Neurons
Hong Chen, Kun Qian, Zhongwei Du, et al.
Cell stem cell (2014) Vol. 14, Iss. 6, pp. 796-809
Open Access | Times Cited: 293
The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer’s Disease and Parkinson’s Disease
Giacomo Monzio Compagnoni, Alessio Di Fonzo, Stefania Corti, et al.
Molecular Neurobiology (2020) Vol. 57, Iss. 7, pp. 2959-2980
Open Access | Times Cited: 281
Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson’s Disease
Maria Nguyen, Yvette C. Wong, Daniel Ysselstein, et al.
Trends in Neurosciences (2018) Vol. 42, Iss. 2, pp. 140-149
Open Access | Times Cited: 270
Investigating human disease using stem cell models
Jared Sterneckert, Peter Reinhardt, Hans R. Schöler
Nature Reviews Genetics (2014) Vol. 15, Iss. 9, pp. 625-639
Closed Access | Times Cited: 238
iPSC-Derived Dopamine Neurons Reveal Differences between Monozygotic Twins Discordant for Parkinson’s Disease
Chris M. Woodard, Brian A. Campos, Sheng‐Han Kuo, et al.
Cell Reports (2014) Vol. 9, Iss. 4, pp. 1173-1182
Open Access | Times Cited: 212
A New Glucocerebrosidase Chaperone Reduces -Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism
Elma Aflaki, Daniel K. Borger, Nima Moaven, et al.
Journal of Neuroscience (2016) Vol. 36, Iss. 28, pp. 7441-7452
Open Access | Times Cited: 212
Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation
Sun Young Chung, Sarah Kishinevsky, Joseph R. Mazzulli, et al.
Stem Cell Reports (2016) Vol. 7, Iss. 4, pp. 664-677
Open Access | Times Cited: 191
Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders
Junchao Tong, Gausiha Rathitharan, Jeffrey H. Meyer, et al.
Brain (2017) Vol. 140, Iss. 9, pp. 2460-2474
Open Access | Times Cited: 176
Mitochondrial quality control in health and in Parkinson’s disease
Mohamed A. Eldeeb, Rhalena A. Thomas, Mohamed A. Ragheb, et al.
Physiological Reviews (2022) Vol. 102, Iss. 4, pp. 1721-1755
Closed Access | Times Cited: 153
Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells
Jenne Tran, Helena Targa Dias Anastacio, Cédric Bardy
npj Parkinson s Disease (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 143
Impaired dopamine release in Parkinson’s disease
Kaitlyn M. L. Cramb, Dayne Beccano-Kelly, Stephanie J. Cragg, et al.
Brain (2023) Vol. 146, Iss. 8, pp. 3117-3132
Open Access | Times Cited: 89
Recent Advances in Methamphetamine Neurotoxicity Mechanisms and Its Molecular Pathophysiology
Shaobin Yu, Ling Zhu, Qiang Shen, et al.
Behavioural Neurology (2015) Vol. 2015, pp. 1-11
Open Access | Times Cited: 162
Antioxidant gene therapy against neuronal cell death
Juliana Navarro-Yepes, Laura Mireya Zavala-Flores, Annadurai Anandhan, et al.
Pharmacology & Therapeutics (2013) Vol. 142, Iss. 2, pp. 206-230
Open Access | Times Cited: 160
Guided Self‐Propelled Leaping of Droplets on a Micro‐Anisotropic Superhydrophobic Surface
Jie Liu, Haoyuan Guo, Bo Zhang, et al.
Angewandte Chemie International Edition (2016) Vol. 55, Iss. 13, pp. 4265-4269
Closed Access | Times Cited: 159
Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
Victorio M. Pozo Devoto, Tomás L. Falzone
Disease Models & Mechanisms (2017) Vol. 10, Iss. 9, pp. 1075-1087
Open Access | Times Cited: 150
Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders
David S. Goldstein, Irwin J. Kopin, Yehonatan Sharabi
Pharmacology & Therapeutics (2014) Vol. 144, Iss. 3, pp. 268-282
Open Access | Times Cited: 149
Physiological Characterisation of Human iPS-Derived Dopaminergic Neurons
Elizabeth M. Hartfield, Michiko Yamasaki-Mann, Hugo J. R. Fernandes, et al.
PLoS ONE (2014) Vol. 9, Iss. 2, pp. e87388-e87388
Open Access | Times Cited: 142
Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson’s disease
Georgia Kouroupi, Era Taoufik, Ioannis S. Vlachos, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 18
Open Access | Times Cited: 139
Cell cycle and p53 gate the direct conversion of human fibroblasts to dopaminergic neurons
Houbo Jiang, Zhimin Xu, Ping Zhong, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 128
Aberrant epigenome in iPSC ‐derived dopaminergic neurons from Parkinson's disease patients
Rubén Fernández‐Santiago, Iria Carballo‐Carbajal, Giancarlo Castellano, et al.
EMBO Molecular Medicine (2015) Vol. 7, Iss. 12, pp. 1529-1546
Open Access | Times Cited: 127
Mitochondrial Alterations by PARKIN in Dopaminergic Neurons Using PARK2 Patient-Specific and PARK2 Knockout Isogenic iPSC Lines
Atossa Shaltouki, Renuka Sivapatham, Ying Pei, et al.
Stem Cell Reports (2015) Vol. 4, Iss. 5, pp. 847-859
Open Access | Times Cited: 127
Page 1 - Next Page

Scroll to top